Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
As per the WHO, “the number of people affected with Diabetes has grown significantly from 108 million in 1980 to 422 million in 2014. A rising trend in prevalence is observed in low- and middle-income countries as compared to high-income countries”. Additionally, Diabetes is a significant cause of the number of dea...
Find More
World Diabetes Day, observed on 14 November every year, aiming to raise awareness about the impact that diabetes has on the family. This year, the theme this day is Family and Diabetes. World Diabetes Day According to a survey by WHO, 425 million people are still struggling with diabetes, and by th...
Find More
The study published in The New England Journal of Medicine set out to study the effect of the drug teplizumab in people at high risk for type 1 diabetes. According to recent Phase II clinical trials, in experimental immunotherapy conducted, the drug has been able to delay the onset of disease for the first tim...
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
